• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

实现 Boston 角膜移植术后最佳术后视力的时间。

Time to achieve best postoperative visual acuity following Boston keratoprosthesis surgery.

机构信息

Faculty of Medicine, Université de Sherbrooke, Sherbrooke, Quebec, Canada.

Department of Ophthalmology, McGill University, Montreal, Quebec, Canada.

出版信息

Br J Ophthalmol. 2022 Jul;106(7):929-934. doi: 10.1136/bjophthalmol-2020-317483. Epub 2021 Mar 3.

DOI:10.1136/bjophthalmol-2020-317483
PMID:33658233
Abstract

BACKGROUND/AIMS: To evaluate the time needed for patients with Boston type 1 keratoprosthesis (KPro) to reach their best-corrected visual acuity (BCVA) and all contributing factors.

METHODS

We retrospectively reviewed 137 consecutive eyes from 118 patients, measured how long they needed to reach their BCVA and looked at factors that might affect this time duration including patient demographics, ocular comorbidities and postoperative complications.

RESULTS

The mean follow-up was 5.49 years. The median time to BCVA postoperatively was 6 months, with 47% of patients achieving their BCVA by 3 months. The mean best achieved logMAR visual acuity was 0.71, representing a gain of 6 lines on the Snellen visual acuity chart. Postoperative glaucoma, retroprosthetic membrane (RPM) and endophthalmitis prolonged this duration. We found no correlation between the following factors and time to BCVA: gender, age, indication for KPro surgery, primary versus secondary KPro, number of previous penetrating keratoplasties, previous retinal surgery, intraoperative anterior vitrectomy and preoperative glaucoma.

CONCLUSION

In our retrospective cohort, the majority of subjects reached their BCVA between 3 and 6 months after KPro implantation. This duration was significantly prolonged by the development of postoperative glaucoma, RPM and endophthalmitis.

摘要

背景/目的:评估波士顿 1 型角膜假体(KPro)患者达到最佳矫正视力(BCVA)所需的时间及其所有影响因素。

方法

我们回顾性分析了 118 例 137 只连续眼,测量了达到 BCVA 所需的时间,并观察了可能影响这一时间的因素,包括患者人口统计学、眼部合并症和术后并发症。

结果

平均随访时间为 5.49 年。术后达到 BCVA 的中位数时间为 6 个月,47%的患者在 3 个月内达到 BCVA。最佳获得的对数视力平均值为 0.71,相当于 Snellen 视力表上提高了 6 行。术后青光眼、后弹力膜(RPM)和眼内炎延长了这一时期。我们发现以下因素与 BCVA 时间之间无相关性:性别、年龄、KPro 手术指征、原发性与继发性 KPro、既往穿透性角膜移植术次数、既往视网膜手术、术中前玻璃体切除术和术前青光眼。

结论

在我们的回顾性队列中,大多数患者在 KPro 植入后 3 至 6 个月达到 BCVA。术后青光眼、RPM 和眼内炎的发生显著延长了这一时期。

相似文献

1
Time to achieve best postoperative visual acuity following Boston keratoprosthesis surgery.实现 Boston 角膜移植术后最佳术后视力的时间。
Br J Ophthalmol. 2022 Jul;106(7):929-934. doi: 10.1136/bjophthalmol-2020-317483. Epub 2021 Mar 3.
2
Glaucoma associated with Boston type I keratoprosthesis.与 Boston Ⅰ型角膜移植术相关的青光眼。
Cornea. 2012 Feb;31(2):134-9. doi: 10.1097/ICO.0b013e31820f7a32.
3
Incidence, risk factors, and treatment of retroprosthetic membranes following Boston keratoprosthesis eyes and the impact of glaucoma surgery.Boston 角膜假体眼后假体后膜的发生率、危险因素和治疗以及青光眼手术的影响。
Graefes Arch Clin Exp Ophthalmol. 2024 Aug;262(8):2561-2567. doi: 10.1007/s00417-024-06445-6. Epub 2024 Mar 19.
4
Longer-term vision outcomes and complications with the Boston type 1 keratoprosthesis at the University of California, Davis.加州大学戴维斯分校波士顿 1 型角膜假体的长期视力结果和并发症。
Ophthalmology. 2011 Aug;118(8):1543-50. doi: 10.1016/j.ophtha.2010.12.032. Epub 2011 Mar 12.
5
Visual Outcomes and Complications of Type I Boston Keratoprosthesis in Children: A Retrospective Multicenter Study and Literature Review.儿童 I 型 Boston 角膜假体的视觉结果和并发症:回顾性多中心研究和文献复习。
Ophthalmology. 2018 Feb;125(2):153-160. doi: 10.1016/j.ophtha.2017.07.009. Epub 2017 Aug 12.
6
Glaucoma Risk Factors and Outcomes Following Boston Keratoprosthesis Type 1 Surgery.Boston 角膜移植术 1 型手术后青光眼的危险因素和结果。
Am J Ophthalmol. 2021 Jun;226:56-67. doi: 10.1016/j.ajo.2021.01.006. Epub 2021 Jan 22.
7
[Long-term visual outcomes of Boston type I keratoprosthesis in Canada].[加拿大波士顿I型人工角膜移植的长期视觉效果]
J Fr Ophtalmol. 2023 Dec;46(10):1212-1221. doi: 10.1016/j.jfo.2023.07.014. Epub 2023 Oct 20.
8
Long-term outcomes following primary versus secondary Boston keratoprosthesis type 1 implantation.原发性与继发性 Boston 角膜移植术 1 型植入术后的长期结果。
Br J Ophthalmol. 2022 Jul;106(7):935-940. doi: 10.1136/bjophthalmol-2020-317606. Epub 2021 Feb 23.
9
Boston type I keratoprosthesis versus penetrating keratoplasty following a single failed corneal graft.波士顿 I 型角膜性角膜移植术与单次角膜移植失败后的穿透性角膜移植术比较。
Eye (Lond). 2023 Feb;37(3):486-491. doi: 10.1038/s41433-022-01969-9. Epub 2022 Feb 15.
10
Visual outcomes of Boston keratoprosthesis implantation as the primary penetrating corneal procedure.作为原发性穿透性角膜手术的 Boston 角膜移植术的视觉结果。
Cornea. 2012 Dec;31(12):1436-40. doi: 10.1097/ICO.0b013e31823f7765.

引用本文的文献

1
Artificial cornea transplantation and visual rehabilitation: an integrative review.人工角膜移植与视觉康复:一项综合综述。
Arq Bras Oftalmol. 2022 Sep 23;87(2):0350. doi: 10.5935/0004-2749.2021-0350. eCollection 2022.
2
The treatment of end-stage corneal disease: penetrating keratoplasty compared with Boston type 1 keratoprosthesis.终末期角膜疾病的治疗:穿透性角膜移植术与波士顿 1 型角膜假体的比较。
Graefes Arch Clin Exp Ophthalmol. 2022 Sep;260(9):2781-2790. doi: 10.1007/s00417-022-05646-1. Epub 2022 Apr 6.